Phenindamine
- TRADE NAME: Nolahist
- INDICATIONS: Allergic rhinitis, urticaria, angioedema
- CLASS: Histamine H1 receptor antagonist
- HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric